PhenomeX (CELL) EBIT

Annual EBIT

-$97.03 M
-$26.42 M-37.42%

December 1, 2022


Summary


Performance

CELL EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCELLprofitabilitymetrics:

Quarterly EBIT

-$48.56 M
-$25.55 M-111.00%

June 1, 2023


Summary


Performance

CELL Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCELLprofitabilitymetrics:

TTM EBIT

-$121.91 M
-$23.05 M-23.31%

June 1, 2023


Summary


Performance

CELL TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherCELLprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CELL EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-37.4%-90.3%-44.3%
3 y3 years-477.3%-302.5%-347.0%
5 y5 years-360.6%-1167.3%-625.3%

CELL EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year+37.4%at low+175.1%at low+72.7%at low
5 y5-year+477.3%at low+1472.1%at low+625.3%at low
alltimeall time+477.3%at low+1472.1%at low+3081.3%at low

PhenomeX EBIT History

DateAnnualQuarterlyTTM
Jun 2023
-
-$48.56 M(+111.0%)
-$121.91 M(+23.3%)
Mar 2023
-
-$23.02 M(-20.7%)
-$98.86 M(+1.9%)
Dec 2022
-$97.03 M(+37.4%)
-$29.02 M(+36.1%)
-$97.03 M(+13.3%)
Sep 2022
-
-$21.32 M(-16.5%)
-$85.67 M(+1.4%)
Jun 2022
-
-$25.52 M(+20.5%)
-$84.47 M(+10.1%)
Mar 2022
-
-$21.18 M(+20.0%)
-$76.73 M(+8.7%)
Dec 2021
-$70.61 M
-$17.66 M(-12.2%)
-$70.61 M(+9.2%)
Sep 2021
-
-$20.12 M(+13.2%)
-$64.69 M(+22.8%)
Jun 2021
-
-$17.77 M(+18.0%)
-$52.69 M(+12.1%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$15.06 M(+28.4%)
-$46.99 M(+17.5%)
Dec 2020
-$39.97 M(+137.8%)
-$11.73 M(+44.5%)
-$39.97 M(+27.6%)
Sep 2020
-
-$8.12 M(-32.7%)
-$31.33 M(+14.9%)
Jun 2020
-
-$12.07 M(+49.9%)
-$27.27 M(+29.7%)
Mar 2020
-
-$8.05 M(+160.7%)
-$21.03 M(+25.1%)
Dec 2019
-$16.81 M(-20.2%)
-$3.09 M(-24.0%)
-$16.81 M(+22.5%)
Sep 2019
-
-$4.07 M(-30.1%)
-$13.72 M(+42.1%)
Jun 2019
-
-$5.82 M(+51.9%)
-$9.65 M(+151.9%)
Mar 2019
-
-$3.83 M
-$3.83 M
Dec 2018
-$21.06 M
-
-

FAQ

  • What is PhenomeX annual earnings before interest & taxes?
  • What is the all time high annual EBIT for PhenomeX?
  • What is PhenomeX annual EBIT year-on-year change?
  • What is PhenomeX quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for PhenomeX?
  • What is PhenomeX quarterly EBIT year-on-year change?
  • What is PhenomeX TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for PhenomeX?
  • What is PhenomeX TTM EBIT year-on-year change?

What is PhenomeX annual earnings before interest & taxes?

The current annual EBIT of CELL is -$97.03 M

What is the all time high annual EBIT for PhenomeX?

PhenomeX all-time high annual earnings before interest & taxes is -$16.81 M

What is PhenomeX annual EBIT year-on-year change?

Over the past year, CELL annual earnings before interest & taxes has changed by -$26.42 M (-37.42%)

What is PhenomeX quarterly earnings before interest & taxes?

The current quarterly EBIT of CELL is -$48.56 M

What is the all time high quarterly EBIT for PhenomeX?

PhenomeX all-time high quarterly earnings before interest & taxes is -$3.09 M

What is PhenomeX quarterly EBIT year-on-year change?

Over the past year, CELL quarterly earnings before interest & taxes has changed by -$23.05 M (-90.32%)

What is PhenomeX TTM earnings before interest & taxes?

The current TTM EBIT of CELL is -$121.91 M

What is the all time high TTM EBIT for PhenomeX?

PhenomeX all-time high TTM earnings before interest & taxes is -$3.83 M

What is PhenomeX TTM EBIT year-on-year change?

Over the past year, CELL TTM earnings before interest & taxes has changed by -$37.44 M (-44.32%)